Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Sports Medicine
Erschienen in: Sports Medicine 4/2016

01.04.2016 | Current Opinion

Endurance Exercise and the Heart: Friend or Foe?

verfasst von: Fabian Sanchis-Gomar, Laura M. Pérez, Michael J. Joyner, Herbert Löllgen, Alejandro Lucia

Erschienen in: Sports Medicine | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Although low- to moderate-intensity exercise has well-known cardiovascular benefits, it has been increasingly suggested that prolonged strenuous endurance exercise (SEE) could have potential deleterious cardiac effects. In effect, the term ‘cardiac overuse injury’ (or ‘over-exercise’) has been recently reported to group all the possible deleterious cardiac consequences of repeated exposure to SEE or ‘over-exercise’. In this article, we provide a balanced overview of the current state of knowledge regarding the ‘pros’ and ‘cons’ of SEE from a cardiological point of view.
Literatur
1.
Horneffer A. Herodot. Historien. Stuttgart: Kröner Comp; 1971.
2.
Lavie CJ, Arena R, Swift DL, et al. Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ Res. 2015;117(2):207–19.PubMedCrossRef
3.
Sanchis-Gomar F, Lucia A, Levine BD. Relationship between strenuous exercise and cardiac “morbimortality”: benefits outweigh the potential risks. Trends Cardiovasc Med. 2015. pii: S1050-1738(15)00189-9 (Epub 5 Aug 2015). doi:10.​1016/​j.​tcm.​2015.​07.​008.PubMed
4.
O’Keefe JH, Patil HR, Lavie CJ, et al. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc. 2012;87(6):587–95.PubMedPubMedCentralCrossRef
5.
O’Keefe JH, Franklin B, Lavie CJ. Exercising for health and longevity vs peak performance: different regimens for different goals. Mayo Clin Proc. 2014;89(9):1171–5.PubMedCrossRef
6.
Williams PT, Thompson PD. Increased cardiovascular disease mortality associated with excessive exercise in heart attack survivors. Mayo Clin Proc. 2014;89(9):1187–94.PubMedCrossRef
7.
Mons U, Hahmann H, Brenner H. A reverse J-shaped association of leisure time physical activity with prognosis in patients with stable coronary heart disease: evidence from a large cohort with repeated measurements. Heart. 2014;100(13):1043–9.PubMedCrossRef
8.
9.
10.
Lavie CJ, O’Keefe JH, Sallis RE. Exercise and the heart: the harm of too little and too much. Curr Sports Med Rep. 2015;14(2):104–9.PubMedCrossRef
11.
O’Keefe JH, Lavie CJ, Guazzi M. Part 1: potential dangers of extreme endurance exercise: how much is too much? Part 2: screening of school-age athletes. Prog Cardiovasc Dis. 2015;57(4):396–405.PubMedCrossRef
12.
Lee DC, Lavie CJ, Vedanthan R. Optimal dose of running for longevity: is more better or worse? J Am Coll Cardiol. 2015;65(5):420–2.PubMedCrossRef
13.
Sanchis-Gomar F, Joyner MJ, Lucia A. Letter by Sanchis-Gomar et al. regarding article, “Cardiac remodeling in response to 1 year of intensive endurance training”. Circulation. 2015;132(11):e146.PubMedCrossRef
14.
Sanchis-Gomar F, Santos-Lozano A, Garatachea N, et al. My patient wants to perform strenuous endurance exercise. What’s the right advice? Int J Cardiol. 2015;197:248–53.PubMedCrossRef
15.
Galderisi M, Cardim N, D’Andrea A, et al. The multi-modality cardiac imaging approach to the Athlete’s heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:353.PubMedCrossRef
16.
Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324(5):295–301.PubMedCrossRef
17.
Fagard R, Van den Broeke C, Amery A. Left ventricular dynamics during exercise in elite marathon runners. J Am Coll Cardiol. 1989;14(1):112–8.PubMedCrossRef
18.
Fagard RH. Impact of different sports and training on cardiac structure and function. Cardiol Clin. 1997;15(3):397–412.PubMedCrossRef
19.
Maron BJ, Pelliccia A, Spataro A, et al. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J. 1993;69(2):125–8.PubMedPubMedCentralCrossRef
20.
Pelliccia A, Maron BJ, De Luca R, et al. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation. 2002;105(8):944–9.PubMedCrossRef
21.
Urhausen A, Albers T, Kindermann W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart. 2004;90(5):496–501.PubMedPubMedCentralCrossRef
22.
Pelliccia A, Culasso F, Di Paolo FM, et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130(1):23–31.PubMedCrossRef
23.
Morganroth J, Maron BJ, Henry WL, et al. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82(4):521–4.PubMedCrossRef
24.
D’Andrea A, Limongelli G, Caso P, et al. Association between left ventricular structure and cardiac performance during effort in two morphological forms of athlete’s heart. Int J Cardiol. 2002;86(2–3):177–84.PubMedCrossRef
25.
George KP, Warburton DE, Oxborough D, et al. Upper limits of physiological cardiac adaptation in ultramarathon runners. J Am Coll Cardiol. 2011;57(6):754–5.PubMedCrossRef
26.
Arbab-Zadeh A, Perhonen M, Howden E, et al. Cardiac remodeling in response to 1 year of intensive endurance training. Circulation. 2014;130(24):2152–61.PubMedCrossRef
27.
La Gerche A, Claessen G. Is exercise good for the right ventricle? Concepts for health and disease. Can J Cardiol. 2015;31(4):502–8.PubMedCrossRef
28.
La Gerche A, Heidbuchel H. Can intensive exercise harm the heart? You can get too much of a good thing. Circulation. 2014;130(12):992–1002.PubMedCrossRef
29.
Trivax JE, Franklin BA, Goldstein JA, et al. Acute cardiac effects of marathon running. J Appl Physiol (1985). 2010;108(5):1148–53.CrossRef
30.
La Gerche A, Burns AT, Mooney DJ, et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012;33(8):998–1006.PubMedCrossRef
31.
Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378(9798):1244–53.PubMedCrossRef
32.
D’Andrea A, Riegler L, Golia E, et al. Range of right heart measurements in top-level athletes: the training impact. Int J Cardiol. 2013;164(1):48–57.PubMedCrossRef
33.
Elliott AD, La Gerche A. The right ventricle following prolonged endurance exercise: are we overlooking the more important side of the heart? A meta-analysis. Br J Sports Med. 2014;49(11):724–9.PubMedCrossRef
34.
Angell PJ, Chester N, Sculthorpe N, et al. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician. Br J Sports Med. 2012;46(Suppl 1):i78–84.PubMedCrossRef
35.
O’Hanlon R, Wilson M, Wage R, et al. Troponin release following endurance exercise: is inflammation the cause? A cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2010;12:38.PubMedPubMedCentralCrossRef
36.
Regwan S, Hulten EA, Martinho S, et al. Marathon running as a cause of troponin elevation: a systematic review and meta-analysis. J Interv Cardiol. 2010;23(5):443–50.PubMedCrossRef
37.
Scherr J, Braun S, Schuster T, et al. 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc. 2011;43(10):1819–27.PubMedCrossRef
38.
Scharhag J, Lollgen H, Kindermann W. Competitive sports and the heart: benefit or risk? Dtsch Arztebl Int. 2013;110(1–2):14–23 (quiz 4, e1–2).PubMedPubMedCentral
39.
Hanssen H, Keithahn A, Hertel G, et al. Magnetic resonance imaging of myocardial injury and ventricular torsion after marathon running. Clin Sci (Lond). 2011;120(4):143–52.PubMedCrossRef
40.
Mousavi N, Czarnecki A, Kumar K, et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol. 2009;103(10):1467–72.PubMedCrossRef
41.
Neilan TG, Yoerger DM, Douglas PS, et al. Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J. 2006;27(9):1079–84.PubMedCrossRef
42.
Gaudreault V, Tizon-Marcos H, Poirier P, et al. Transient myocardial tissue and function changes during a marathon in less fit marathon runners. Can J Cardiol. 2013;29(10):1269–76.PubMedCrossRef
43.
Saltin B. Aerobic work capacity and circulation at exercise in man. With special reference to the effect of prolonged exercise and/or heat exposure. Acta Physiol Scand Suppl. 1964;Suppl 230:1–52.
44.
Utomi V, Oxborough D, Ashley E, et al. Predominance of normal left ventricular geometry in the male ‘athlete’s heart’. Heart. 2014;100(16):1264–71.PubMedCrossRef
45.
Rimensberger C, Carlen F, Brugger N, et al. Right ventricular adaptations and arrhythmias in amateur ultra-endurance athletes. Br J Sports Med. 2014;48(15):1179–84.PubMedCrossRef
46.
Sanchis-Gomar F, Garatachea N, Catalan P, et al. Strenuous endurance exercise and right ventricular systolic function: no evidence of long-term sequelae. Int J Cardiol. 2015;179:297–8.PubMedCrossRef
47.
La Gerche A, Connelly KA, Mooney DJ, et al. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart. 2008;94(7):860–6.PubMedCrossRef
48.
La Gerche A, Heidbuchel H, Burns AT, et al. Disproportionate exercise load and remodeling of the athlete’s right ventricle. Med Sci Sports Exerc. 2011;43(6):974–81.PubMedCrossRef
49.
Scharhag J, Schneider G, Urhausen A, et al. Athlete’s heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol. 2002;40(10):1856–63.PubMedCrossRef
50.
Dalla Vecchia L, Traversi E, Porta A, et al. On site assessment of cardiac function and neural regulation in amateur half marathon runners. Open Heart. 2014;1(1):e000005.PubMedPubMedCentralCrossRef
51.
Schattke S, Xing Y, Lock J, et al. Increased longitudinal contractility and diastolic function at rest in well-trained amateur Marathon runners: a speckle tracking echocardiography study. Cardiovasc Ultrasound. 2014;12:11.PubMedPubMedCentralCrossRef
52.
Zaidi A, Ghani S, Sharma R, et al. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation. 2013;127(17):1783–92.PubMedCrossRef
53.
Dangardt FJ, McKenna WJ, Luscher TF, et al. Exercise: friend or foe? Nat Rev Cardiol. 2013;10(9):495–507.PubMedCrossRef
54.
Pluim BM, Zwinderman AH, van der Laarse A, et al. The athlete’s heart a meta-analysis of cardiac structure and function. Circulation. 2000;101(3):336–44.PubMedCrossRef
55.
Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114(15):1633–44.PubMedCrossRef
56.
Ector J, Ganame J, van der Merwe N, et al. Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur Heart J. 2007;28(3):345–53.PubMedCrossRef
57.
Heidbuchel H, Hoogsteen J, Fagard R, et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J. 2003;24(16):1473–80.PubMedCrossRef
58.
Arbab-Zadeh A, Dijk E, Prasad A, et al. Effect of aging and physical activity on left ventricular compliance. Circulation. 2004;110(13):1799–805.PubMedCrossRef
59.
Bhella PS, Hastings JL, Fujimoto N, et al. Impact of lifelong exercise “dose” on left ventricular compliance and distensibility. J Am Coll Cardiol. 2014;64(12):1257–66.PubMedPubMedCentralCrossRef
60.
Waterhouse DF, Ismail TF, Prasad SK, et al. Imaging focal and interstitial fibrosis with cardiovascular magnetic resonance in athletes with left ventricular hypertrophy: implications for sporting participation. Br J Sports Med. 2012;46(Suppl 1):i69–77.PubMedCrossRef
61.
Naylor LH, George K, O’Driscoll G, et al. The athlete’s heart: a contemporary appraisal of the ‘Morganroth hypothesis’. Sports Med. 2008;38(1):69–90.PubMedCrossRef
62.
Löllgen H, Löllgen R. Genetics, genetic testing and sports: aspects from sports cardiology. Genomics Soc Policy. 2012;8:32–47.
63.
Levine BD. Can intensive exercise harm the heart? The benefits of competitive endurance training for cardiovascular structure and function. Circulation. 2014;130(12):987–91.PubMedCrossRef
64.
Breuckmann F, Mohlenkamp S, Nassenstein K, et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology. 2009;251(1):50–7.PubMedCrossRef
65.
Wilson M, O’Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol (1985). 2011;110(6):1622–6.CrossRef
66.
Prakken NH, Teske AJ, Cramer MJ, et al. Head-to-head comparison between echocardiography and cardiac MRI in the evaluation of the athlete’s heart. Br J Sports Med. 2012;46(5):348–54.PubMedCrossRef
67.
Marra MP, De Lazzari M, Zorzi A, et al. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Heart Rhythm. 2014;11(5):856–63.CrossRef
68.
69.
Guasch E, Benito B, Qi X, et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol. 2013;62(1):68–77.PubMedCrossRef
70.
Wilhelm M, Roten L, Tanner H, et al. Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes. Am J Cardiol. 2011;108(4):580–5.PubMedCrossRef
71.
Turagam MK, Velagapudi P, Kocheril AG. Atrial fibrillation in athletes. Am J Cardiol. 2012;109(2):296–302.PubMedCrossRef
72.
Turagam MK, Velagapudi P, Alpert MA. Does exercise cause atrial fibrillation? Int J Cardiol. 2015;181:245–6.PubMedCrossRef
73.
Mozaffarian D, Furberg CD, Psaty BM, et al. Physical activity and incidence of atrial fibrillation in older adults: the Cardiovascular Health Study. Circulation. 2008;118(8):800–7.PubMedPubMedCentralCrossRef
74.
Kwok CS, Anderson SG, Myint PK, et al. Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2014;177(2):467–76.PubMedCrossRef
75.
Drca N, Wolk A, Jensen-Urstad M, et al. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart. 2014;100(13):1037–42.PubMedCrossRef
76.
Elosua R, Arquer A, Mont L, et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol. 2006;108(3):332–7.PubMedCrossRef
77.
Molina L, Mont L, Marrugat J, et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace. 2008;10(5):618–23.PubMedCrossRef
78.
Mont L, Sambola A, Brugada J, et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J. 2002;23(6):477–82.PubMedCrossRef
79.
80.
Furlanello F, Bertoldi A, Dallago M, et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol. 1998;9(8 Suppl):S63–8.PubMed
81.
Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46(4):690–6.PubMedCrossRef
82.
Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11(9):1156–9.PubMedCrossRef
83.
Thelle DS, Selmer R, Gjesdal K, et al. Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women. Heart. 2013;99(23):1755–60.PubMedCrossRef
84.
Andersen K, Farahmand B, Ahlbom A, et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J. 2013;34(47):3624–31.PubMedCrossRef
85.
Myrstad M, Lochen ML, Graff-Iversen S, et al. Increased risk of atrial fibrillation among elderly Norwegian men with a history of long-term endurance sport practice. Scand J Med Sci Sports. 2014;24(4):e238–44.PubMedPubMedCentralCrossRef
86.
Qureshi WT, Alirhayim Z, Blaha MJ, et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) Project. Circulation. 2015;131(21):1827–34.PubMedCrossRef
87.
Sofi F, Capalbo A, Cesari F, et al. Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15(3):247–57.PubMedCrossRef
88.
Lollgen H, Bockenhoff A, Knapp G. Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med. 2009;30(3):213–24.PubMedCrossRef
89.
Samitz G, Egger M, Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol. 2011;40(5):1382–400.PubMedCrossRef
90.
Nocon M, Hiemann T, Muller-Riemenschneider F, et al. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil. 2008;15(3):239–46.PubMedCrossRef
91.
Sattelmair J, Pertman J, Ding EL, et al. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation. 2011;124(7):789–95.PubMedPubMedCentralCrossRef
92.
Moore SC, Patel AV, Matthews CE, et al. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med. 2012;9(11):e1001335.PubMedPubMedCentralCrossRef
93.
Schnohr P, O’Keefe JH, Marott JL, et al. Dose of jogging and long-term mortality: the Copenhagen City Heart Study. J Am Coll Cardiol. 2015;65(5):411–9.PubMedCrossRef
94.
Lee DC, Pate RR, Lavie CJ, et al. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol. 2014;64(5):472–81.PubMedPubMedCentralCrossRef
95.
Sanchis-Gomar F, Pareja-Galeano H, Santos-Lozano A, et al. Strenuous exercise worse than sedentarism? J Am Coll Cardiol. 2015;65(24):2673–4.PubMedCrossRef
96.
Schnohr P, Marott JL, Lange P, et al. Longevity in male and female joggers: the Copenhagen City Heart Study. Am J Epidemiol. 2013;177(7):683–9.PubMedCrossRef
97.
Chakravarty EF, Hubert HB, Lingala VB, et al. Reduced disability and mortality among aging runners: a 21-year longitudinal study. Arch Intern Med. 2008;168(15):1638–46.PubMedPubMedCentralCrossRef
98.
Williams PT. Reductions in incident coronary heart disease risk above guideline physical activity levels in men. Atherosclerosis. 2009;209(2):524–7.PubMedPubMedCentralCrossRef
99.
Chomistek AK, Cook NR, Flint AJ, et al. Vigorous-intensity leisure-time physical activity and risk of major chronic disease in men. Med Sci Sports Exerc. 2012;44(10):1898–905.PubMedPubMedCentralCrossRef
100.
Garatachea N, Santos-Lozano A, Sanchis-Gomar F, et al. Elite athletes live longer than the general population: a meta-analysis. Mayo Clin Proc. 2014;89(9):1195–200.PubMedCrossRef
101.
Kettunen JA, Kujala UM, Kaprio J, et al. All-cause and disease-specific mortality among male, former elite athletes: an average 50-year follow-up. Br J Sports Med. 2015;49(13):893–7.PubMedCrossRef
102.
Farahmand BY, Ahlbom A, Ekblom O, et al. Mortality amongst participants in Vasaloppet: a classical long-distance ski race in Sweden. J Intern Med. 2003;253(3):276–83.PubMedCrossRef
103.
Kujala UM, Sarna S, Kaprio J. Use of medications and dietary supplements in later years among male former top-level athletes. Arch Intern Med. 2003;163(9):1064–8.PubMedCrossRef
104.
Marijon E, Tafflet M, Antero-Jacquemin J, et al. Mortality of French participants in the Tour de France (1947–2012). Eur Heart J. 2013;34(40):3145–50.PubMedCrossRef
105.
Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol. 2003;42(11):1959–63.PubMedCrossRef
106.
Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation. 2009;119(8):1085–92.PubMedCrossRef
107.
Maron BJ, Haas TS, Doerer JJ, et al. Comparison of US and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol. 2009;104(2):276–80.PubMedCrossRef
108.
Albert CM, Mittleman MA, Chae CU, et al. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med. 2000;343(19):1355–61.PubMedCrossRef
109.
Holst AG, Winkel BG, Theilade J, et al. Incidence and etiology of sports-related sudden cardiac death in Denmark: implications for preparticipation screening. Heart Rhythm. 2010;7(10):1365–71.PubMedCrossRef
110.
Kim JH, Malhotra R, Chiampas G, et al. Cardiac arrest during long-distance running races. N Engl J Med. 2012;366(2):130–40.PubMedCrossRef
111.
Mathews SC, Narotsky DL, Bernholt DL, et al. Mortality among marathon runners in the United States, 2000–2009. Am J Sports Med. 2012;40(7):1495–500.PubMedCrossRef
112.
Harris KM, Henry JT, Rohman E, et al. Sudden death during the triathlon. JAMA. 2010;303(13):1255–7.PubMedCrossRef
113.
Mohlenkamp S, Lehmann N, Breuckmann F, et al. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008;29(15):1903–10.PubMedCrossRef
114.
Haskell WL, Sims C, Myll J, et al. Coronary artery size and dilating capacity in ultradistance runners. Circulation. 1993;87(4):1076–82.PubMedCrossRef
115.
Zilinski JL, Contursi ME, Isaacs SK, et al. Myocardial adaptations to recreational marathon training among middle-aged men. Circ Cardiovasc Imaging. 2015;8(2):e002487.PubMedCrossRef
116.
Metadaten
Titel
Endurance Exercise and the Heart: Friend or Foe?
verfasst von
Fabian Sanchis-Gomar
Laura M. Pérez
Michael J. Joyner
Herbert Löllgen
Alejandro Lucia
Publikationsdatum
01.04.2016
Verlag
Springer International Publishing
Erschienen in
Sports Medicine / Ausgabe 4/2016
Print ISSN: 0112-1642
Elektronische ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-015-0434-4

Weitere Artikel der Ausgabe 4/2016

Sports Medicine 4/2016 Zur Ausgabe

Systematic Review

The ‘Quiet Eye’ and Motor Performance: A Systematic Review Based on Newell’s Constraints-Led Model

Systematic Review

Application of Global Positioning System and Microsensor Technology in Competitive Rugby League Match-Play: A Systematic Review and Meta-analysis

Erratum

Erratum to: Effect of Training Leading to Repetition Failure on Muscular Strength: A Systematic Review and Meta-Analysis

Original Research Article

Cross-Sectional Association Between Normal-Range Lactate Dehydrogenase, Physical Activity and Cardiovascular Disease Risk Score

Systematic Review

Can Water Temperature and Immersion Time Influence the Effect of Cold Water Immersion on Muscle Soreness? A Systematic Review and Meta-Analysis

Systematic Review

At What Age Do Children and Adolescents Develop Lower Limb Tendon Pathology or Tendinopathy? A Systematic Review and Meta-analysis

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise